CN107669915A - Treat sophora bud oral liquid of cardiovascular and cerebrovascular diseases and preparation method thereof - Google Patents
Treat sophora bud oral liquid of cardiovascular and cerebrovascular diseases and preparation method thereof Download PDFInfo
- Publication number
- CN107669915A CN107669915A CN201711198169.2A CN201711198169A CN107669915A CN 107669915 A CN107669915 A CN 107669915A CN 201711198169 A CN201711198169 A CN 201711198169A CN 107669915 A CN107669915 A CN 107669915A
- Authority
- CN
- China
- Prior art keywords
- parts
- oral liquid
- sophora bud
- cardiovascular
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000219784 Sophora Species 0.000 title claims abstract description 30
- 239000007788 liquid Substances 0.000 title claims abstract description 28
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 23
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 22
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims description 7
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 244000307697 Agrimonia eupatoria Species 0.000 claims abstract description 8
- 235000000125 common agrimony Nutrition 0.000 claims abstract description 8
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 7
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 7
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 7
- 241000522254 Cassia Species 0.000 claims abstract description 7
- 241000756943 Codonopsis Species 0.000 claims abstract description 7
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 7
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 7
- 241000756137 Hemerocallis Species 0.000 claims abstract description 7
- 239000009636 Huang Qi Substances 0.000 claims abstract description 7
- 244000241872 Lycium chinense Species 0.000 claims abstract description 7
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 7
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 7
- 241000521581 Millettia Species 0.000 claims abstract description 7
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 7
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 7
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 7
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 7
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 7
- 235000008434 ginseng Nutrition 0.000 claims abstract description 7
- 235000005412 red sage Nutrition 0.000 claims abstract description 7
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 6
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000722949 Apocynum Species 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000012423 maintenance Methods 0.000 claims description 2
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract description 2
- 208000006011 Stroke Diseases 0.000 abstract description 2
- 230000000747 cardiac effect Effects 0.000 abstract description 2
- 230000002490 cerebral effect Effects 0.000 abstract description 2
- 241000722948 Apocynum cannabinum Species 0.000 abstract 1
- 230000003516 hyperlipidaemic effect Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010033664 Panic attack Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention provides a kind of sophora bud oral liquid for treating cardiovascular and cerebrovascular diseases, and bulk drug is made up of following component:The sophora bud, the red sage root, Radix Angelicae Sinensis, Radix Codonopsis, the fleece-flower root, the Radix Astragali, ginseng, the radix paeoniae rubrathe, pseudo-ginseng, rhizoma Gastrodiae, the fruit of Chinese wolfberry, safflower, Chinese cassia tree, cortex acanthopanacis, cassia seed, day lily, reticulate millettia, hairyvein agrimony, gynostemma pentaphylla, folium cortex eucommiae, honeysuckle, cultivated land, ground bettle, earthworm, bluish dogbane, radix glycyrrhizae, the oral liquid are adapted to:Hypertension, hyperlipemic patients, cardiac, cerebral apoplexy sequela patient etc..
Description
Technical field
The invention belongs to technical field of traditional Chinese medicines, and in particular to a kind of sophora bud oral liquid for treating cardiovascular and cerebrovascular diseases and its preparation
Method.
Background technology
Due to the horizontal continuous improvement of modern society's life, physical demands is increasingly reduced again, and the fat deposition in human body is bright
Aobvious increase, overweight people troop expand increasingly, and data are shown:Germany population 61,400,000, super severe one account for more than 50%, Mexico
The people of swelling fertilizer accounts for 44%, and Switzerland, Australia are all more than 40%, and Chinese 70,000,000 people are fat, and 200,000,000 people are overweight;Obesity is not only society
Problem, and be also very big medical problem, obesity is hypertension, high fat of blood, the hyperglycaemia seed of trouble.
People's trembled with fear, the wet, stasis of blood, acid are that cardiovascular and cerebrovascular disease forms the seed of trouble;After cold, the wet invasion and attack body vital organs of the human body, cause body
Empty, immunity degradation, cold, wet development cause cyclic metabolism obstacle, slow blood flow, flow velocity slowly causes pressure into toxin, rubbish
Increase, the lipid material in blood can precipitate, and be attached on vascular wall, and formation blood vessel is thicker, luminal stenosis, adds
A large amount of arteriosclerosis plaques and lipid deposition, cause angiemphraxis, and supply of blood flow interrupts, and endovascular toxicant is not easy to arrange
Go out;If blood viscosity is too high, resistance increase, at this moment if vasopasm, then hypertension can be produced suddenly, if in blood
Lipid material be deposited in angiocarpy, then cause coronary heart disease, be deposited in the cerebrovascular, then cause cerebrovascular disease.
The treatment method of traditional heart and brain disease is mainly decompression, lipid-loweringing, support, bridging, and therapeutic effect is not ideal, therefore,
It is necessary to develop a kind of sophora bud oral liquid for treating cardiovascular and cerebrovascular diseases.
The content of the invention
An object of the present invention is to provide a kind of sophora bud oral liquid for treating cardiovascular and cerebrovascular diseases, the oral liquid energy of the sophora bud
Enough treat a variety of cardiovascular and cerebrovascular diseases.
The second object of the present invention is the preparation method for providing above-mentioned sophora bud oral liquid.
The sophora bud oral liquid of present invention treatment cardiovascular and cerebrovascular diseases, in terms of weight fraction, is made up of the following raw material:With weight point
Number meter, bulk drug are made up of following component:
Sophora bud 350-450 parts, red sage root 250-350 parts, Radix Angelicae Sinensis 200-300 parts, Radix Codonopsis 200-300 parts, fleece-flower root 200-300 parts,
Radix Astragali 150-250 parts, ginseng 200-300 parts, radix paeoniae rubrathe 150-250 parts, pseudo-ginseng 200-300 parts, rhizoma Gastrodiae 200-300 parts, the fruit of Chinese wolfberry
200-300 parts, safflower 100-200 parts, Chinese cassia tree 200-300 parts, cortex acanthopanacis 250-350 parts, cassia seed 200-300 parts, day lily
350-450 parts, reticulate millettia 300-400 parts, hairyvein agrimony 250-350 parts, gynostemma pentaphylla 250-350 parts, folium cortex eucommiae 250-350 parts, gold
Honeysuckle flower 250-350 parts, cultivated land 250-350 parts, ground bettle 200-300 parts, earthworm 150-250 parts, bluish dogbane 250-350 parts are sweet
Careless 150-250 parts.
The preferred 360-440 parts of the wherein described sophora bud, the preferred 270-340 parts of the red sage root, the preferred 210-290 parts of Radix Angelicae Sinensis, Radix Codonopsis
It is preferred that 220-290 parts.
The preferred 210-280 parts of the wherein described fleece-flower root, the preferred 160-240 parts of the Radix Astragali, the preferred 220-280 parts of ginseng are red
The preferred 160-240 parts of Chinese herbaceous peony.
The preferred 230-280 parts of wherein described pseudo-ginseng, the preferred 230-270 parts of rhizoma Gastrodiae, the preferred 220-270 parts of the fruit of Chinese wolfberry.
The preferred 130-170 parts of wherein described safflower, the preferred 220-270 parts of Chinese cassia tree, the preferred 280-320 parts of cortex acanthopanacis, certainly
The preferred 230-280 parts of pine torch.
The preferred 360-430 parts of wherein described day lily, the preferred 320-390 parts of reticulate millettia, the preferred 270-330 of hairyvein agrimony
Part, the preferred 270-340 parts of gynostemma pentaphylla.
The preferred 270-320 parts of wherein described folium cortex eucommiae, the preferred 280-320 parts of honeysuckle, the preferred 280-320 parts of cultivated land,
The preferred 230-270 parts of ground bettle.
Wherein described preferred 170-230 parts of earthworm, the preferred 280-320 parts of bluish dogbane, the preferred 180-210 parts of radix glycyrrhizae.
The present invention optimal technical solution be:A kind of herbal wine, in terms of weight fraction, bulk drug is by following component system
Into:500 parts of the sophora bud, 300 parts of the red sage root, 250 parts of Radix Angelicae Sinensis, 250 parts of Radix Codonopsis, 250 parts of the fleece-flower root, 200 parts of the Radix Astragali, 250 parts of ginseng are red
200 parts of Chinese herbaceous peony, 250 parts of pseudo-ginseng, 250 parts of rhizoma Gastrodiae, 250 parts of the fruit of Chinese wolfberry, 150 parts of safflower, 250 parts of Chinese cassia tree, 300 parts of cortex acanthopanacis, Cassia
250 parts of son, 400 parts of day lily, 350 parts of reticulate millettia, 300 parts of hairyvein agrimony, 300 parts of gynostemma pentaphylla, 300 parts of folium cortex eucommiae, honeysuckle 300
Part, 300 parts of cultivated land, 250 parts of ground bettle, 200 parts of earthworm, 300 parts of bluish dogbane, 200 parts of radix glycyrrhizae.
The preparation method of the sophora bud oral liquid of present invention treatment cardiovascular and cerebrovascular diseases in turn includes the following steps:
(1)The raw material weighed up is put into decocting container, adds water, boiled rear slow fire is decocted 20-40 minutes, and maintenance boiling water is
Can;Wherein the weight ratio of Chinese medicine material and water is 1:(3-5);
(2)By well-done medical filtration;It is filling.
The sophora bud oral liquid instructions of taking of present invention treatment cardiovascular and cerebrovascular diseases is as follows:Warmly take 3 times a day, each 50-
100ml。
The sophora bud oral liquid of present invention treatment cardiovascular and cerebrovascular diseases is adapted to following condition subject:Hypertension, high fat of blood and mistake
Dormancy patient, cardiac, cerebral apoplexy sequela patient etc..
Embodiment
Embodiment of the present invention is described in detail below in conjunction with example, but those skilled in the art will manage
Solution, the following example is merely to illustrate the present invention, and should not be taken as limiting the scope of the invention.
Table 1 is raw material and quality used in embodiment 1-6, comparative example 1-2, and comparative example 1 is on the basis of embodiment 1
Cortex acanthopanacis is eliminated, comparative example 2 is to eliminate hairyvein agrimony on the basis of embodiment 1.
Table 1, unit are gram
。
Each embodiment, the preparation method of comparative example sophora bud oral liquid include:
(1)The raw material weighed up is put into decocting container, adds water, boiled rear slow fire is decocted 30 minutes, maintains boiling water;Its
The weight ratio of middle Chinese medicine material and water is 1:4;
(2)By well-done medical filtration;It is filling.
Each embodiment, the application experiment method of comparative example sophora bud oral liquid are as follows.
A groups:
Coronary Heart Disease Patients 80 are treated, are divided into 8 groups, every group of 10 people, every group of patient takes embodiment 1-6, comparative example 1-2 mouth respectively
Liquid is taken, 3 times a day, each 50mL, 40 minutes warm boiled waters before meals, 30 days are 1 course for the treatment of, take 6 courses for the treatment of.
B groups:Thrombolysis contrasts, and patient 90, is divided into 9 groups, every group of 10 people, every group is taken embodiment 1-6, comparative example 1- respectively
2 oral liquid, one group is that western drug is treated(Control group), 3 times a day, each 50mL, 40 minutes warm boiled waters before meals, 30 days
For 1 course for the treatment of, 2 courses for the treatment of are taken, two groups of patients compare at age, sex, thrombosis position, the course of disease, clinical manifestation etc.
Compared with no significant difference.
Experimental result:
A groups:The symptom of the preceding patient of medication is nervous, shortness of breath, is felt suffocated, and the irregular panic attacks in chest, is breathed on foot, legs and feet without
Power, electrocardiogram show blood supply wretched insufficiency, and average S-T segment declines 0.9 millimeter before medication.
That takes patients with coronary artery disease after 6 courses for the treatment of the results are shown in Table 2.
Table 2
。
B groups:The evaluated order of severity of thrombosis patients is suitable before medication, and patient is in age, sex, thrombosis position, disease
Journey, clinical manifestation etc. comparing difference are without conspicuousness;Medicine of the present invention, without complication, has no haemorrhage during thrombolysis
Shape, occasionally there is patient slight gastrointestinal reaction occur, disappeared after giving anti symptom treatment.
The experimental result of thrombosis patients is shown in Table 3 after taking 60 days.
Table 3
。
Model case:So-and-so is shut out, 55 years old, patients with coronary heart disease, finds there is old antetheca cardiac muscle stalk in medication the first two months
Extremely, electrocardiogram V2-V4QS ripples, T ripples be inverted, take 1 oral liquid of embodiment after 2 months patient symptom be obviously improved, electrocardiogram recover
Normally.
Above content describes the general principle and principal character of the present invention, and the present invention is not limited to the above embodiments,
Without departing from the spirit and scope of the present invention, various changes and modifications of the present invention are possible, and these changes and improvements are all
Fall into scope of the claimed invention.
Claims (10)
1. a kind of sophora bud oral liquid for treating cardiovascular and cerebrovascular diseases, it is characterised in that in terms of weight fraction, bulk drug is by following component
It is made:500 parts of the sophora bud, red sage root 250-350 parts, Radix Angelicae Sinensis 200-300 parts, Radix Codonopsis 200-300 parts, fleece-flower root 200-300 parts, the Radix Astragali
150-250 parts, ginseng 200-300 parts, radix paeoniae rubrathe 150-250 parts, pseudo-ginseng 200-300 parts, rhizoma Gastrodiae 200-300 parts, fruit of Chinese wolfberry 200-
300 parts, safflower 100-200 parts, Chinese cassia tree 200-300 parts, cortex acanthopanacis 250-350 parts, cassia seed 200-300 parts, day lily 350-
450 parts, reticulate millettia 300-400 parts, hairyvein agrimony 250-350 parts, gynostemma pentaphylla 250-350 parts, folium cortex eucommiae 250-350 parts, honeysuckle
250-350 parts, cultivated land 250-350 parts, ground bettle 200-300 parts, earthworm 150-250 parts, bluish dogbane 250-350 parts, radix glycyrrhizae
150-250 parts.
2. the sophora bud oral liquid for the treatment of cardiovascular and cerebrovascular diseases according to claim 1, it is characterised in that red sage root 270-340
Part, when being classified as 210-290 parts, Radix Codonopsis is 220-290 parts.
3. the sophora bud oral liquid for the treatment of cardiovascular and cerebrovascular diseases according to claim 1, it is characterised in that fleece-flower root 210-280
Part, the Radix Astragali is 160-240 parts, and ginseng is 220-280 parts, and the radix paeoniae rubrathe is 160-240 parts.
4. the sophora bud oral liquid for the treatment of cardiovascular and cerebrovascular diseases according to claim 1, it is characterised in that pseudo-ginseng 230-280
Part, rhizoma Gastrodiae is 230-270 parts, and the fruit of Chinese wolfberry is 220-270 parts.
5. the sophora bud oral liquid for the treatment of cardiovascular and cerebrovascular diseases according to claim 1, it is characterised in that safflower 130-170
Part, Chinese cassia tree is 220-270 parts, and cortex acanthopanacis is 280-320 parts, and cassia seed is 230-280 parts.
6. the sophora bud oral liquid for the treatment of cardiovascular and cerebrovascular diseases according to claim 1, it is characterised in that day lily 360-430
Part, reticulate millettia is 320-390 parts, and hairyvein agrimony is 270-330 parts, and gynostemma pentaphylla is 270-340 parts.
7. the sophora bud oral liquid for the treatment of cardiovascular and cerebrovascular diseases according to claim 1, it is characterised in that folium cortex eucommiae 270-320
Part, honeysuckle is 280-320 parts, and cultivated land is 280-320 parts, and ground bettle is 230-270 parts.
8. the sophora bud oral liquid for the treatment of cardiovascular and cerebrovascular diseases according to claim 1, it is characterised in that earthworm 170-230
Part, bluish dogbane is 280-320 parts, and radix glycyrrhizae is 180-210 parts.
9. the sophora bud oral liquid for the treatment of cardiovascular and cerebrovascular diseases according to claim 1, it is characterised in that former in terms of weight fraction
Material medicine is made up of following component:500 parts of the sophora bud, 300 parts of the red sage root, 250 parts of Radix Angelicae Sinensis, 250 parts of Radix Codonopsis, 250 parts of the fleece-flower root, the Radix Astragali
200 parts, 250 parts of ginseng, 200 parts of the radix paeoniae rubrathe, 250 parts of pseudo-ginseng, 250 parts of rhizoma Gastrodiae, 250 parts of the fruit of Chinese wolfberry, 150 parts of safflower, Chinese cassia tree 250
Part, 300 parts of cortex acanthopanacis, 250 parts of cassia seed, 400 parts of day lily, 350 parts of reticulate millettia, 300 parts of hairyvein agrimony, 300 parts of gynostemma pentaphylla, Du
300 parts of Zhong Ye, 300 parts of honeysuckle, 300 parts of cultivated land, 250 parts of ground bettle, 200 parts of earthworm, 300 parts of bluish dogbane, 200 parts of radix glycyrrhizae.
10. the preparation method of the sophora bud oral liquid of the treatment cardiovascular and cerebrovascular diseases according to claim 1, it is characterised in that bag
Include following steps:
(1)The raw material weighed up is put into decocting container, adds water, boiled rear slow fire is decocted 20-40 minutes, and maintenance boiling water is
Can;Wherein the weight ratio of Chinese medicine material and water is 1:(3-5);
(2)By well-done medical filtration;It is filling.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711198169.2A CN107669915A (en) | 2017-11-25 | 2017-11-25 | Treat sophora bud oral liquid of cardiovascular and cerebrovascular diseases and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711198169.2A CN107669915A (en) | 2017-11-25 | 2017-11-25 | Treat sophora bud oral liquid of cardiovascular and cerebrovascular diseases and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107669915A true CN107669915A (en) | 2018-02-09 |
Family
ID=61150305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711198169.2A Pending CN107669915A (en) | 2017-11-25 | 2017-11-25 | Treat sophora bud oral liquid of cardiovascular and cerebrovascular diseases and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107669915A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1840149A (en) * | 2006-01-19 | 2006-10-04 | 邢法田 | Medicinal pill for treating cardiovascular and cerebrovascular disease and its preparing process |
US7234931B2 (en) * | 2004-09-01 | 2007-06-26 | Haeng Woo Lee | Functional food composition having effects of relieving alcohol-induced hangover symptoms and improving liver function |
CN101229252A (en) * | 2008-01-18 | 2008-07-30 | 重庆大学 | Agrimony total flavone extract, preparing method and applications thereof |
CN104825682A (en) * | 2015-04-22 | 2015-08-12 | 李学香 | Traditional Chinese medicine for treatment of coronary heart disease angina pectoris |
-
2017
- 2017-11-25 CN CN201711198169.2A patent/CN107669915A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7234931B2 (en) * | 2004-09-01 | 2007-06-26 | Haeng Woo Lee | Functional food composition having effects of relieving alcohol-induced hangover symptoms and improving liver function |
CN1840149A (en) * | 2006-01-19 | 2006-10-04 | 邢法田 | Medicinal pill for treating cardiovascular and cerebrovascular disease and its preparing process |
CN101229252A (en) * | 2008-01-18 | 2008-07-30 | 重庆大学 | Agrimony total flavone extract, preparing method and applications thereof |
CN104825682A (en) * | 2015-04-22 | 2015-08-12 | 李学香 | Traditional Chinese medicine for treatment of coronary heart disease angina pectoris |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101181600B (en) | Traditional Chinese medicine composition for curing cardiovascular and cerebrovascular diseases | |
CN101559152A (en) | Chinese materia medica preparation for treating hydrocephalus and preparation method thereof | |
CN100333750C (en) | Traditional Chinese medicine preparation for treating thoracic obstruction and palpitation and preparation method thereof | |
CN103948882A (en) | Traditional Chinese medicine for treating thrombus | |
CN107669915A (en) | Treat sophora bud oral liquid of cardiovascular and cerebrovascular diseases and preparation method thereof | |
CN104524342B (en) | A kind of four drop protects the preparation method of first Chinese medicine preparation and its paste | |
CN101129464A (en) | Traditional Chinese medicine composition for qi-benefitting blood circulation promoting and eliminating stasis activating meridian and processes for producing same | |
CN107854623A (en) | Treat sophora bud Chinese medicine composition of cardiovascular and cerebrovascular diseases and preparation method thereof | |
CN104857289A (en) | Ginseng preparation for reducing blood glucose and blood pressure and preparation method of ginseng preparation | |
CN104208609B (en) | It is peaceful to pacify brain | |
CN107714958A (en) | Sophora bud Chinese medicine composition and preparation method thereof | |
CN103908490A (en) | Pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and preparation method thereof | |
CN103142894B (en) | Traditional Chinese medicine composition for rehabilitation of tumor patients after radiotherapy and chemotherapy, and preparation method thereof | |
CN101744912A (en) | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
CN104189419A (en) | Healthy life prolonging cream | |
CN101134069B (en) | Capsule for treating hieronosus | |
CN104758578A (en) | Traditional Chinese medicine composition for treating palpitation | |
CN102716293A (en) | Capsule for treating hypertension, hyperlipemia, arteriosclerosis and coronary heart disease | |
CN104013686B (en) | A kind of medicine being used for the treatment of prolapse of lumbar intervertebral disc and preparation method thereof | |
CN108671105A (en) | A kind of solution Yu Shu god's capsules and preparation method thereof | |
CN102327410A (en) | Traditional Chinese medicine composition for treating epigastric fullness | |
CN101549133B (en) | Ablation and embolism extinguishing preparation of Chinese medicine | |
CN102266528B (en) | Medicament for treating hypertension | |
CN106581553A (en) | Lozenge utilizing biological extract to treat cardio-cerebrovascular diseases and preparation method thereof | |
CN104208570A (en) | Traditional Chinese medicinal composition for treating heart failure, and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180209 |